Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia.

The Journal of Biological Chemistry
R de JongJ Groffen

Abstract

The deregulated tyrosine kinase activity of the Bcr/Abl protein has been causally linked to the development of Philadelphia (Ph) chromosome-positive leukemia in mice and man. Abnormally tyrosine-phosphorylated substrates of the Bcr/Abl kinase in Ph-positive cells are likely to contribute to leukemogenesis by interfering with normal signal transduction pathways. We have previously shown that the adaptor molecule Crkl is a major in vivo substrate for the Bcr/Abl tyrosine kinase, and it is thought to connect Bcr/Abl with downstream effectors. In the current study, a tyrosine-phosphorylated protein with a molecular mass of approximately 120 kDa was identified which binds only to the Crkl Src homology 2 (SH2) domain in cells, including Ph-positive patient material, containing an active Bcr/Abl protein. We demonstrate here that this protein is Cbl, originally discovered as an oncogene which induces B-cell and myeloid leukemias in mice. The Crkl SH2 domain binds specifically to Cbl. The Src homology 3 (SH3) domains of Crkl do not bind to Cbl, but do bind Bcr/Abl. These findings suggest the existence of a trimolecular complex involving Bcr/Abl, Crkl, and Cbl and are consistent with a model in which Crkl mediates the oncogenic signal of...Continue Reading

References

Mar 15, 1990·Nature·N HeisterkampJ Groffen
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W Y LangdonH C Morse
Mar 10, 1995·The Journal of Biological Chemistry·R SalgiaT Ernst

❮ Previous
Next ❯

Citations

Dec 22, 1999·Biochemical and Biophysical Research Communications·T ImaizumiK Yamamura
May 10, 2001·International Journal of Hematology·M Sattler, J D Griffin
Sep 5, 2006·Reviews in Endocrine & Metabolic Disorders·Angela Bruzzaniti, Roland Baron
Jan 17, 2004·Experimental Hematology·Isabelle GastonBrian J Druker
Aug 28, 1998·Cellular Signalling·Y C Liu, A Altman
Nov 1, 1996·The Journal of Experimental Medicine·Y OtaL E Samelson
May 24, 2011·Biochimica Et Biophysica Acta·Zsofia SzentpeteryTamas Balla
Apr 8, 1999·Leukemia & Lymphoma·K S KolibabaB J Druker
Feb 1, 2005·Biochimica Et Biophysica Acta·Kazuya Machida, Bruce J Mayer
Jun 29, 2005·Biochemical and Biophysical Research Communications·Young Jin ChoNora Heisterkamp
Jan 27, 1998·Hematology/oncology Clinics of North America·C M Verfaillie
Apr 2, 1998·Hematology/oncology Clinics of North America·C M Verfaillie
Jul 22, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Stefania TrinoPellegrino Musto
Apr 22, 2009·PloS One·Ramarao VepacheduRafeul Alam
Oct 25, 1996·The Journal of Biological Chemistry·A Y TsygankovJ B Bolen
Mar 28, 1997·The Journal of Biological Chemistry·C J Fitzer-AttasZ Eshhar
Dec 5, 2003·Oncogene·Daniela M DinulescuBrian J Druker
May 29, 2002·Oncogene·Blanca Scheijen, James D Griffin
Apr 3, 2001·Nature Reviews. Molecular Cell Biology·C B Thien, W Y Langdon
Jan 16, 2018·Nature Biotechnology·Michael BoettcherMichael T McManus
Oct 18, 1996·The Journal of Biological Chemistry·J A DonovanL E Samelson
Jun 27, 1997·The Journal of Biological Chemistry·A BhatB J Druker
Feb 13, 1999·The Journal of Biological Chemistry·Z ZhangY C Liu
Jan 24, 1998·The Journal of Biological Chemistry·R de JongJ Groffen
Jul 10, 1999·The Journal of Biological Chemistry·B FernándezH Meisner
May 16, 1998·The Journal of Biological Chemistry·M DeckertY C Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.